Those trials have now been reported, and they complicate the picture
How AOD 9604 Differs From the Peptides It Gets Grouped With AOD 9604 is frequently mentioned alongside compounds like CJC-1295, Ipamorelin, and other growth-hormone-related peptides, which leads to the assumption that protocols are interchangeable
She was born to be an injector
The SELECT trial (N=17,604), published in the New England Journal of Medicine in 2023, showed that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in overweight or obese adults without diabetes over a median follow-up of 34.2 months
For a detailed look at how compounded semaglutide differs from brand-name versions, the complete guide covers manufacturing, quality, and regulatory considerations